SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is trending with retail traders actively discussing price targets and potential for a short squeeze. Despite recent earnings and raised guidance, some express concern over market conditions and volatility. Optimistic investors point to institutional ownership, AI momentum, and potential government reopening as catalysts for a rebound.

Zcash is a decentralized and open-source cryptocurrency that offers privacy and selective transparency of transactions. Zcash payments are published on a public blockchain, but the sender, recipient, and amount of a transaction remain private.  Zcash is based on peer-reviewed cryptographic research, and built by a security-specialized engineering team on an open source platform based on Bitcoin Core's battle-tested codebase. Our improvement over Bitcoin is the addition of privacy. Zcash uses advanced cryptographic techniques, namely zero-knowledge proofs, to guarantee the validity of transactions without revealing additional information about them.  How Zcash works  Zcash encrypts the contents of shielded transactions. Since the payment information is encrypted, the protocol uses a novel cryptographic method to verify their validity.  Zcash uses a zero-knowledge proof construction called a zk-SNARK, developed by our team of experienced cryptographers based on recent breakthroughs in cryptography. These constructions allow the network to maintain a secure ledger of balances without disclosing the parties or amounts involved. Instead of publicly demonstrating spend-authority and transaction values, the transaction metadata is encrypted and zk-SNARKs are used to prove that nobody is cheating or stealing.  Zcash also enables users to send public payments which work similarly to Bitcoin. With the support for both shielded and transparent addresses, users can choose to send Zcash privately or publicly. Zcash payments sent from a shielded address to a transparent address reveal the received balance, while payments from a transparent address to a shielded address protect the receiving value.   Check out CoinBureau for guide on What is ZCash.

Zcash

Zcash is trending as investors flock to privacy coins, with community members discussing its potential to reach $1,000 and comparing it to Bitcoin's early days. A recent Coindesk article has added fuel to the fire, while some traders are pointing to a pullback. The coin's limited supply and focus on shielded transactions are key talking points.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisk Corp. is trending due to optimism around its potential in the inference market and high-bandwidth flash memory, with community members drawing comparisons to past high-growth tech stories. Despite some bearish sentiment focused on profitability, bullish traders are pointing to future earnings estimates and significant volume spikes as potential catalysts. The stock's parabolic year-to-date performance and analyst upgrades are fueling FOMO, while others caution about overvaluation and potential manipulation.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer's stock is active amid an ongoing bidding war with Novo Nordisk for Metsera, a company focused on obesity drugs, with Pfizer filing lawsuits to challenge Novo's acquisition. The community is discussing the implications of this battle, Pfizer's overall strategy in the weight loss market, and whether the company is overpaying for potential acquisitions. Additionally, the stock's dividend and recent earnings are focal points of conversation.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending amidst an ongoing bidding war with Pfizer for Metsera and speculation around upcoming announcements regarding GLP-1 drug pricing and FDA approval for an oral version of Wegovy. Community discussions revolve around the potential impact of a deal with the Trump administration on drug prices and market access, as well as concerns about company management and strategic direction given these developments.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy`s Co

Wendy's ($WEN) is trending as community members discuss its recent earnings beat and subsequent stock reversal, closing lower despite initial gains. Investors are weighing the impact of store closures and a turnaround plan amidst leadership uncertainty, while some speculate on the potential for a short squeeze or buyout.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

Kendu is trending as the community rallies around its real-world applications, from Kendu Energy drinks to Kendu Spice.  Enthusiasts are actively discussing the growing number of holders and the brand's increasing visibility. The community emphasizes Kendu's unique position as a permissionless brand with various IRL businesses and initiatives.

Evaxion AS engages in the discovery and development of immunotherapies for cancer and infectious diseases. Its technologies include the immuno-oncology platform PIONEER, the bacterial disease platform EDEN, the viral disease platform RAVEN, and the proprietary AI platform technology ObsERV. The company was founded by Niels Iversen Møller and Andreas Holm Mattsson on August 11, 2008 and is headquartered in Hoersholm, Denmark.

Evaxion A/S - ADR

Evaxion Biotech

EVAX is trending amid discussions around AI-designed cancer vaccine data and upcoming presentations, with the community speculating about potential partnerships and buyout opportunities, particularly with Merck. Bullish sentiment is fueled by the company's AI platform and positive trial results, though some traders are wary of short-term volatility and dilution risks. The stock's low market cap and upcoming catalysts are also key talking points.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

Shares of TGTX are active amid ongoing discussions about the company's future, with speculation around a potential buyout driven by recent executive stock transfers and comparisons to similar moves before other acquisitions. The community is also weighing the impact of Briumvi sales, potential buybacks, and government scrutiny of drug pricing on the stock's valuation. Many are expressing frustration with the stock's performance despite positive company developments, while some continue to point to technical indicators.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

VKTX is trending amid speculation of a potential acquisition, fueled by ongoing bidding wars in the obesity drug sector and community discussion around $BMY's possible interest. Community members are debating whether Viking will remain independent or be acquired, with some suggesting a price tag of at least $15B, while others discuss potential partnerships and the impact of competitor deals on Viking's valuation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Amprius Technologies (NYSE:AMPX) Trading Up 12.7% on Strong Earnings

Amprius Technologies (NYSE:AMPX) Trading 12.7% Higher Following Better-Than-Expected Earnings...

Amprius Technologies Signals Electrifying Growth in 2026

Amprius Technologies is gaining business momentum that will spill over into its stock price, driving it to new all-time highs in 2026...

Best Lithium Stocks Worth Watching - November 7th

QuantumScape, Amprius Technologies, and Critical Metals are the three Lithium stocks to watch today, according to MarketBeat's stock screener tool. Lithium stocks are shares of companies involved in...

<ul class="summary-bullets"><li>The jump in sales was propelled by both new customers and expanded orders from existing clients.</li><li>Both Q3 revenue and EPS came in above the Street estimates.&nbsp;</li><li>Amprius ended the quarter with $73.2 million in cash and zero debt.</li></ul>Amprius Technologies, Inc. (AMPX) stock drew increased retail chatter on Friday after the company reported strong third-quarter (Q3) revenue supported by a rise in new customers and larger orders from existing ones.The firm reported a Q3 revenue of $21.4 million, marking a 42% year-on-year (YoY) surge, and posted a loss per share (EPS) of $0.03. Both revenue and EPS figures came in better than the analysts’ consensus estimates of $17.46 million in revenue and a loss per share of $0.06, respectively, according to Fiscal AI data.&nbsp;<h2 class="st-heading-2">Customer Momentum</h2>According to the lithium-ion battery producer, the surge in sales was driven by both new customers and increased orders from existing clients. Only one customer accounted for more than 10% of Q3 revenue, reflecting increased diversification.&nbsp;The backlog stood at $53.3 million, including a $35 million order from a UAS manufacturer, representing an 83% quarter-on-quarter increase.&nbsp;<a href="https://stocktwits.com/symbol/AMPX">Amprius’ stock</a> traded over 2% higher on Friday, after the morning bell.&nbsp;Amprius ended the quarter with $73.2 million in cash and zero debt. Operating cash flow used was $9.2 million.<h2 class="st-heading-2">What Are Stocktwits Users Saying?</h2>On Stocktwits, retail sentiment around the stock improved to ‘extremely bullish’ from ‘bullish’ territory the previous day. Message volume shifted to ‘extremely high’ from ‘high’ levels in 24 hours.&nbsp;<figure class="image"><img style="aspect-ratio:930/108;" src="https://news.stocktwits-cdn.com/Screenshot_2025_11_07_092845_png_189cfd2fa6.webp" alt="AMPX’s Sentiment Meter and Message Volume as of 09:15 a.m. ET on Nov. 7, 2025 | Source: Stocktwits" width="930" height="108"><figcaption>AMPX’s Sentiment Meter and Message Volume as of 09:15 a.m. ET on Nov. 7, 2025 | Source: Stocktwits</figcaption></figure>The stock experienced a 286% surge in user message count over 24 hours.&nbsp;A Stocktwits user called the timing perfect for loading the shares, highlighting the gloomy overall market sentiment.&nbsp;<stembedurl>https://stocktwits.com/lejonpung/message/635325511</stembedurl>The company is expanding supply-chain capacity and manufacturing at its Fremont, California, facility with support from a $12 million contract awarded in Q3 by the U.S. Government’s Defense Innovation Unit.AMPX stock has gained over 303% in 2025 and over 781% in the last 12 months.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-did-navitas-semiconductor-stock-tumble-14-percent--pre-market-today/cL2vyvlRETu">Why Did Navitas Semiconductor Stock Tumble 14% Pre-Market Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

08 October 2025, Schleswig-Holstein, Kiel: Dan Cook, head of the US company Lyten, holds a battery in the Landtag. 

AMPX Stock Sees Over 280% Surge In Retail Chatter Over 24 Hours: What’s Driving The Investor Interest? 

The jump in sales was propelled by both new customers and expanded orders from existing clients.

Equity

The company’s third-quarter revenue surged 42% year-over-year to $21.4 million while it reported a loss per share of $0.03.


Amprius Technologies (NYSE:AMPX) Posts Quarterly Earnings Results, Beats Estimates By $0.03 EPS

Amprius Technologies (NYSE:AMPX - Get Free Report) posted its quarterly earnings data on Thursday. The company reported ($0.03) earnings per share for the quarter, topping the consensus estimate of...

Amprius Technologies (AMPX) Reports Q3 Loss, Beats Revenue Estimates

Amprius (AMPX) delivered earnings and revenue surprises of +50.00% and +25.56%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Amprius Technologies (NYSE:AMPX) Stock Price Down 13.5% - Here's Why

Amprius Technologies (NYSE:AMPX) Trading Down 13.5% - Here's What Happened...

Amprius Technologies Reports Third Quarter 2025 Business and Financial Results

Amprius Technologies, Inc. ('Amprius'), (NYSE: AMPX), a leader in next-generation lithium-ion batteries with its Silicon Anode Platform, today announced its business and financial results for the...

Best Lithium Stocks To Follow Today - November 6th

QuantumScape, Enovix, and Amprius Technologies are the three Lithium stocks to watch today, according to MarketBeat's stock screener tool. Lithium stocks are shares of publicly traded companies...

Amprius Technologies Set to Report Q3 Earnings: What's in the Offing?

AMPX is poised for another strong quarter, with third-quarter 2025 revenues expected to more than double on new customers and expanding markets.

Amprius Technologies, Inc. engages in the development, manufacture, and market lithium-ion batteries for mobility applications, including the aviation, electric vehicle and light electric vehicle industries. It operates through the United States and Rest of the World geographical segments. The company was founded by Mark C. Platshon in 2008 and headquartered in Fremont, CA.

Amprius Technologies Inc

$ASTS

$RKLB

$BBAI

$NBIS

Which earnings release are you most excited for the week of Nov. 10? 
 
Drop a comment for others.

Current Price	$12.73
Prev Close	$11.26
Open	$11.84
Dividend Yield	0.00%
50-Day Moving Average	$11.15
Beta	1.94
Avg. Volume	9.6M
PE Ratio	-30.98

52-Week High	$16.03
52-Week Low	$1.63
Market Capitalization	$1.59B
EPS (Annual)	-$0.4456
Price to Book	21.80
Revenue Per Employee	$281,011.63
Enterprise Value/EBITDA	N/A

AMPX
Amprius Technologies Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest AMPX News

AMPXAmprius Technologies Inc